Zimbabwe has declined a major American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive information.
This move became public following a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
An official representative later stated that the US was requesting biological samples for scientific study and profit but was unwilling to guarantee the benefits from any future vaccines.
"We are forced to start the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more dialogue to reach a agreement suitable to all parties so the country's vital HIV programme can continue.
Wider Context
This rejection follows a comparable situation in neighbouring Kenya, where a high court suspended a similar health funding agreement after concerns were raised about the security of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance transparency and accountability.
Based on reports, 16 African countries have to date agreed to these new health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information for a long time, with no corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," Mangwana explained.
"In essence, our country would supply the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our people if a future pandemic arise."
Sovereignty and International Frameworks
He also pointed out that the American exit from the global health body and its push of one-on-one deals were upending systems previously set up via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This system is intended to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
These objections over the US deal "should not be misconstrued as opposition to America," he added.
"We welcome further discussions with our American counterparts on how subsequent collaboration could be designed in a manner that honours the sovereignty and interests of both nations."
Medical Community Response
Medical experts stated it acknowledged the government's concerns, but urged that talks need to persist given that a large portion of the country's Aids initiatives relied on international support.
"If specific concerns exist, such as those involving information security or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," it commented.
The halted deal underscores the ongoing tensions between receiving crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.